UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000003653
Receipt number R000004426
Scientific Title Phase II study of S-1 plus amrubicin as the 2nd-line treatment for non-small cell lung cancer without EGFR mutation
Date of disclosure of the study information 2010/05/25
Last modified on 2017/07/11 09:31:53

No. Disposal Last modified on Item of update
1 Insert 2010/05/24 08:42:22
2 Update 2010/11/30 18:00:11 Name of person sending information
Organization
Division name
Address
3 Update 2011/05/24 09:58:53 Recruitment status
4 Update 2013/11/18 12:48:45 TEL
Email
Address
Email
Post marketing survey by drug manufacture etc., specified by Japanese law.
5 Update 2013/11/18 12:49:19 Recruitment status
Publication of results
6 Update 2017/07/11 09:31:53 Name of primary person or sponsor
Organization